Viewing Study NCT01684761

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:45 AM
Ignite Modification Date: 2026-03-13 @ 4:44 AM
Study NCT ID: NCT01684761
Status: COMPLETED
Last Update Posted: 2017-01-10
First Post: 2012-09-11
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis
Sponsor: Opexa Therapeutics, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Autoimmune Diseases of the Nervous System View
None Multiple Sclerosis View
None Secondary Progressive Multiple Sclerosis View
None Disease Progression View
None Brain Atrophy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Multicenter Study View
None Randomized Controlled Trial View
None Individualized Medicine View
None Immunotherapy View
None Myelin Proteins View
None Biological Agents View